Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03636100 · ClinicalTrials.gov registry record
Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)
A clinical trial, sponsored by Saint Luke's Health System.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03636100: Clinical Trial study, sponsored by Saint Luke's Health System.
NCT03636100 is a clinical trial that was terminated before completion, run by Saint Luke's Health System. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03636100 was terminated before completion, sponsored by Saint Luke's Health System.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Determine whether the presence of acetylcholine in the systemic circulation, correlates with the hypotensive response observed during the thaw phase of cryoballoon ablation.
Primary Outcome
With each subject serving as their own control, acetylcholine levels between ablation applications will be compared followed by a hypotensive response vs those that are not using paired T-tests.
Interventions
- DEVICE Cryoballoon ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2019-10-11 |
Why NCT03636100 stopped before completion
NCT03636100 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cryoballoon ablation is the first listed.
NCT03636100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03636100 about?
NCT03636100 is a clinical study titled "Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)". Determine whether the presence of acetylcholine in the systemic circulation, correlates with the hypotensive response observed during the thaw phase of cryoballoon ablation.
What is the current status of trial NCT03636100?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2018-08-15. Estimated completion is 2019-10-11.
What interventions are being tested in trial NCT03636100?
The interventions under investigation include: Cryoballoon ablation (DEVICE).
Who is sponsoring clinical trial NCT03636100?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI